<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36585109</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>07</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2090-1224</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><PubDate><Year>2023</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Journal of advanced research</Title><ISOAbbreviation>J Adv Res</ISOAbbreviation></Journal><ArticleTitle>GPX4 deficiency-dependent phospholipid peroxidation drives motor deficits of ALS.</ArticleTitle><Pagination><StartPage>205</StartPage><EndPage>218</EndPage><MedlinePgn>205-218</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jare.2022.02.016</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2090-1232(22)00060-1</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease characterized by oxidative stress that triggers motor neurons loss in the brain and spinal cord. However, the mechanisms underlying the exact role of oxidative stress in ALS-associated neural degeneration are not definitively established. Oxidative stress-generated phospholipid peroxides are known to have extensive physiological and pathological consequences to tissues. Here, we discovered that the deficiency of glutathione peroxidase 4 (GPX4), an essential antioxidant peroxidase, led to the accumulation of phospholipid peroxides and resulted in a loss of motor neurons in spinal cords of ALS mice. Mutant human SOD1<sup>G93A</sup> transgenic mice were intrathecally injected with neuron-targeted adeno-associated virus (AAV) expressing GPX4 (GPX4-AAV) or phospholipid peroxidation inhibitor, ferrostatin-1. The results showed that impaired motor performance and neural loss induced by SOD1<sup>G93A</sup> toxicity in the lumbar spine were substantially alleviated by ferrostatin-1 treatment and AAV-mediated GPX4 delivery. In addition, the denervation of neuron-muscle junction and spinal atrophy in ALS mice were rescued by neural GPX4 overexpression, suggesting that GPX4 is essential for the motor neural maintenance and function. In comparison, conditional knockdown of Gpx4 in the spinal cords of Gpx4<sup>fl/fl</sup> mice triggered an obvious increase of phospholipid peroxides and the occurrence of ALS-like motor phenotype. Altogether, our findings underscore the importance of GPX4 in maintaining phospholipid redox homeostasis in the spinal cord and presents GPX4 as an attractive therapeutic target for ALS treatment.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022. Production and hosting by Elsevier B.V.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tu</LastName><ForeName>Long-Fang</ForeName><Initials>LF</Initials><AffiliationInfo><Affiliation>Guangdong Engineering Research Center of Chinese Medicine &amp; Disease Susceptibility, Jinan University, Guangzhou 510632, China; International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chinese Ministry of Education (MOE), College of Pharmacy, Jinan University, Guangzhou 510632, China; Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou 510632, China; Computer-Aided Drug Discovery Research Center, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Tian-Ze</ForeName><Initials>TZ</Initials><AffiliationInfo><Affiliation>Guangdong Engineering Research Center of Chinese Medicine &amp; Disease Susceptibility, Jinan University, Guangzhou 510632, China; International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chinese Ministry of Education (MOE), College of Pharmacy, Jinan University, Guangzhou 510632, China; Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou 510632, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Yang-Fan</ForeName><Initials>YF</Initials><AffiliationInfo><Affiliation>Guangdong Engineering Research Center of Chinese Medicine &amp; Disease Susceptibility, Jinan University, Guangzhou 510632, China; International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chinese Ministry of Education (MOE), College of Pharmacy, Jinan University, Guangzhou 510632, China; Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou 510632, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Qing-Qing</ForeName><Initials>QQ</Initials><AffiliationInfo><Affiliation>Guangdong Engineering Research Center of Chinese Medicine &amp; Disease Susceptibility, Jinan University, Guangzhou 510632, China; International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chinese Ministry of Education (MOE), College of Pharmacy, Jinan University, Guangzhou 510632, China; Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou 510632, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gong</LastName><ForeName>Hai-Biao</ForeName><Initials>HB</Initials><AffiliationInfo><Affiliation>Guangdong Engineering Research Center of Chinese Medicine &amp; Disease Susceptibility, Jinan University, Guangzhou 510632, China; International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chinese Ministry of Education (MOE), College of Pharmacy, Jinan University, Guangzhou 510632, China; Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou 510632, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Lei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Guangdong Engineering Research Center of Chinese Medicine &amp; Disease Susceptibility, Jinan University, Guangzhou 510632, China; International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chinese Ministry of Education (MOE), College of Pharmacy, Jinan University, Guangzhou 510632, China; Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou 510632, China; School of Traditional Chinese Medicine, Jinan University, Guangzhou 510632, China. Electronic address: leiliang@jnu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hai</LastName><ForeName>Lin-Na</ForeName><Initials>LN</Initials><AffiliationInfo><Affiliation>Guangdong Engineering Research Center of Chinese Medicine &amp; Disease Susceptibility, Jinan University, Guangzhou 510632, China; International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chinese Ministry of Education (MOE), College of Pharmacy, Jinan University, Guangzhou 510632, China; Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou 510632, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>You</LastName><ForeName>Nan-Xin</ForeName><Initials>NX</Initials><AffiliationInfo><Affiliation>Guangdong Engineering Research Center of Chinese Medicine &amp; Disease Susceptibility, Jinan University, Guangzhou 510632, China; International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chinese Ministry of Education (MOE), College of Pharmacy, Jinan University, Guangzhou 510632, China; Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou 510632, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>South China Research Center for Acupuncture and Moxibustion, Medical College of Acu-Moxi and Rehabilitation, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yong-Jun</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>South China Research Center for Acupuncture and Moxibustion, Medical College of Acu-Moxi and Rehabilitation, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mo</LastName><ForeName>Xu-Kai</ForeName><Initials>XK</Initials><AffiliationInfo><Affiliation>Medical Imaging Center, First Affiliated Hospital of Jinan University, Guangzhou 510632, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Chang-Zheng</ForeName><Initials>CZ</Initials><AffiliationInfo><Affiliation>Medical Imaging Center, First Affiliated Hospital of Jinan University, Guangzhou 510632, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Liang-Ping</ForeName><Initials>LP</Initials><AffiliationInfo><Affiliation>Medical Imaging Center, First Affiliated Hospital of Jinan University, Guangzhou 510632, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Wan-Yang</ForeName><Initials>WY</Initials><AffiliationInfo><Affiliation>Guangdong Engineering Research Center of Chinese Medicine &amp; Disease Susceptibility, Jinan University, Guangzhou 510632, China; International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chinese Ministry of Education (MOE), College of Pharmacy, Jinan University, Guangzhou 510632, China; Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou 510632, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duan</LastName><ForeName>Wen-Jun</ForeName><Initials>WJ</Initials><AffiliationInfo><Affiliation>Guangdong Engineering Research Center of Chinese Medicine &amp; Disease Susceptibility, Jinan University, Guangzhou 510632, China; International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chinese Ministry of Education (MOE), College of Pharmacy, Jinan University, Guangzhou 510632, China; Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou 510632, China; School of Traditional Chinese Medicine, Jinan University, Guangzhou 510632, China. Electronic address: duanwj@jnu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kurihara</LastName><ForeName>Hiroshi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Guangdong Engineering Research Center of Chinese Medicine &amp; Disease Susceptibility, Jinan University, Guangzhou 510632, China; International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chinese Ministry of Education (MOE), College of Pharmacy, Jinan University, Guangzhou 510632, China; Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou 510632, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yi-Fang</ForeName><Initials>YF</Initials><AffiliationInfo><Affiliation>Guangdong Engineering Research Center of Chinese Medicine &amp; Disease Susceptibility, Jinan University, Guangzhou 510632, China; International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chinese Ministry of Education (MOE), College of Pharmacy, Jinan University, Guangzhou 510632, China; Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou 510632, China. Electronic address: liyifang706@jnu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Rong-Rong</ForeName><Initials>RR</Initials><AffiliationInfo><Affiliation>Guangdong Engineering Research Center of Chinese Medicine &amp; Disease Susceptibility, Jinan University, Guangzhou 510632, China; International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chinese Ministry of Education (MOE), College of Pharmacy, Jinan University, Guangzhou 510632, China; Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou 510632, China; School of Traditional Chinese Medicine, Jinan University, Guangzhou 510632, China. Electronic address: rongronghe@jnu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Egypt</Country><MedlineTA>J Adv Res</MedlineTA><NlmUniqueID>101546952</NlmUniqueID><ISSNLinking>2090-1224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C573944">ferrostatin-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.11.1.9</RegistryNumber><NameOfSubstance UI="D005979">Glutathione Peroxidase</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010545">Peroxides</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010743">Phospholipids</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.11.1.9</RegistryNumber><NameOfSubstance UI="C000611332">glutathione peroxidase 4, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005979" MajorTopicYN="Y">Glutathione Peroxidase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010545" MajorTopicYN="N">Peroxides</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010743" MajorTopicYN="Y">Phospholipids</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">GPX4</Keyword><Keyword MajorTopicYN="N">Phospholipid peroxidation</Keyword><Keyword MajorTopicYN="N">SOD1(G93A) transgenic mice</Keyword><Keyword MajorTopicYN="N">Spinal cord</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>11</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>1</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>30</Day><Hour>20</Hour><Minute>58</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36585109</ArticleId><ArticleId IdType="pmc">PMC9811330</ArticleId><ArticleId IdType="doi">10.1016/j.jare.2022.02.016</ArticleId><ArticleId IdType="pii">S2090-1232(22)00060-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Longo D.L., Brown R.H., Al-Chalabi A. Amyotrophic Lateral Sclerosis. N Engl J Med. 2017;377(2):162&#x2013;172.</Citation><ArticleIdList><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan M.C., Vucic S., Cheah B.C., Turner M.R., Eisen A., Hardiman O., et al. Amyotrophic lateral sclerosis. Lancet. 2011;377(9769):942&#x2013;955.</Citation><ArticleIdList><ArticleId IdType="pubmed">21296405</ArticleId></ArticleIdList></Reference><Reference><Citation>van Es M.A., Hardiman O., Chio A., Al-Chalabi A., Pasterkamp R.J., Veldink J.H., et al. Amyotrophic lateral sclerosis. Lancet. 2017;390(10107):2084&#x2013;2098.</Citation><ArticleIdList><ArticleId IdType="pubmed">28552366</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A., Logroscino G., Hardiman O., Swingler R., Mitchell D., Beghi E., et al. Prognostic factors in ALS: A critical review. Amyotroph lateral Scler Off Publ World Fed Neurol Res Gr Mot Neuron Dis. 2009;10(5-6):310&#x2013;323.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3515205</ArticleId><ArticleId IdType="pubmed">19922118</ArticleId></ArticleIdList></Reference><Reference><Citation>Nowicka N., Juranek J., Juranek J.K., Wojtkiewicz J. Risk Factors and Emerging Therapies in Amyotrophic Lateral Sclerosis. Int J Mol Sci. 2019 May;20(11):2616. doi: 10.3390/ijms20112616.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20112616</ArticleId><ArticleId IdType="pmc">PMC6600314</ArticleId><ArticleId IdType="pubmed">31141951</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L.u., Chen L.u., Wang S., Feng J., Liu L., Liu G., et al. Incidence and prevalence of amyotrophic lateral sclerosis in urban China: a national population-based study. J Neurol Neurosurg Psychiatry. 2020;91(5):520&#x2013;525.</Citation><ArticleIdList><ArticleId IdType="pubmed">32139654</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthur K.C., Calvo A., Price T.R., Geiger J.T., Chi&#xf2; A., Traynor B.J. Projected increase in amyotrophic lateral sclerosis from 2015 to 2040. Nat Commun. 2016 Aug;7:12408.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4987527</ArticleId><ArticleId IdType="pubmed">27510634</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Gall L., Anakor E., Connolly O., Vijayakumar U., Duddy W., Duguez S. Molecular and Cellular Mechanisms Affected in ALS. J Pers Med. 2020 Aug;10(3):101. doi: 10.3390/jpm10030101.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm10030101</ArticleId><ArticleId IdType="pmc">PMC7564998</ArticleId><ArticleId IdType="pubmed">32854276</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong L., McCoy M., Komuro H., West X.Z., Yakubenko V., Gao D., et al. Inflammation-dependent oxidative stress metabolites as a hallmark of amyotrophic lateral sclerosis. Free Radic Biol Med. 2022;178:125&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8744315</ArticleId><ArticleId IdType="pubmed">34871763</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson C., Heiman-Patterson T., Kittrell P., Baranovsky T., McAnanama G., Bower L., et al. Radicava (edaravone) for amyotrophic lateral sclerosis: US experience at 1 year after launch. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20(7-8):605&#x2013;610.</Citation><ArticleIdList><ArticleId IdType="pubmed">31364409</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshino H. Edaravone for the treatment of amyotrophic lateral sclerosis. Expert Rev Neurother. 2019;19(3):185&#x2013;193.</Citation><ArticleIdList><ArticleId IdType="pubmed">30810406</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A., Mazzini L., Mora G. Disease-modifying therapies in amyotrophic lateral sclerosis. Neuropharmacology. 2020;167:107986.</Citation><ArticleIdList><ArticleId IdType="pubmed">32062193</ArticleId></ArticleIdList></Reference><Reference><Citation>Sultana R., Perluigi M., Butterfield D.A. Lipid peroxidation triggers neurodegeneration: a redox proteomics view into the Alzheimer disease brain. Free Radic Biol Med. 2013;62:157&#x2013;169.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3573239</ArticleId><ArticleId IdType="pubmed">23044265</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang W., SriRamaratnam R., Welsch M., Shimada K., Skouta R., Viswanathan V., et al. Regulation of ferroptotic cancer cell death by GPX4. Cell. 2014;156(1-2):317&#x2013;331.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4076414</ArticleId><ArticleId IdType="pubmed">24439385</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M., Liu C.-Y., Wang T., Yu H.-M., Ouyang S.-H., Wu Y.-P., et al. (+)-Clausenamide protects against drug-induced liver injury by inhibiting hepatocyte ferroptosis. Cell Death Dis. 2020;11(9):781.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7502081</ArticleId><ArticleId IdType="pubmed">32951003</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedmann Angeli J.P., Schneider M., Proneth B., Tyurina Y.Y., Tyurin V.A., Hammond V.J., et al. Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat Cell Biol. 2014;16(12):1180&#x2013;1191.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4894846</ArticleId><ArticleId IdType="pubmed">25402683</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Michaelis E.K. Selective neuronal vulnerability to oxidative stress in the brain. Front Aging Neurosci. 2010;2:12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2874397</ArticleId><ArticleId IdType="pubmed">20552050</ArticleId></ArticleIdList></Reference><Reference><Citation>Simpson E.P., Henry Y.K., Henkel J.S., Smith R.G., Appel S.H. Increased lipid peroxidation in sera of ALS patients: a potential biomarker of disease burden. Neurology. 2004;62(10):1758&#x2013;1765.</Citation><ArticleIdList><ArticleId IdType="pubmed">15159474</ArticleId></ArticleIdList></Reference><Reference><Citation>Pisoschi A.M., Pop A. The role of antioxidants in the chemistry of oxidative stress: A review. Eur J Med Chem. 2015;97:55&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">25942353</ArticleId></ArticleIdList></Reference><Reference><Citation>Shibata N., Nagai R., Uchida K., Horiuchi S., Yamada S., Hirano A., et al. Morphological evidence for lipid peroxidation and protein glycoxidation in spinal cords from sporadic amyotrophic lateral sclerosis patients. Brain Res. 2001;917(1):97&#x2013;104.</Citation><ArticleIdList><ArticleId IdType="pubmed">11602233</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith R.G., Henry Y.K., Mattson M.P., Appel S.H. Presence of 4-hydroxynonenal in cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosis. Ann Neurol. 1998;44(4):696&#x2013;699.</Citation><ArticleIdList><ArticleId IdType="pubmed">9778272</ArticleId></ArticleIdList></Reference><Reference><Citation>Kagan V.E., Mao G., Qu F., Angeli J.P.F., Doll S., Croix C.S., et al. Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis. Nat Chem Biol. 2017;13(1):81&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5506843</ArticleId><ArticleId IdType="pubmed">27842066</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang S., Chapa-Dubocq X.R., Tyurina Y.Y., St Croix C.M., Kapralov A.A., Tyurin V.A., et al. Elucidating the contribution of mitochondrial glutathione to ferroptosis in cardiomyocytes. Redox Biol. 2021;45:102021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8187237</ArticleId><ArticleId IdType="pubmed">34102574</ArticleId></ArticleIdList></Reference><Reference><Citation>Savaskan N.E., Ufer C., K&#xfc;hn H., Borchert A. Molecular biology of glutathione peroxidase 4: from genomic structure to developmental expression and neural function. Biol Chem. 2007 Oct;388(10):1007&#x2013;1017.</Citation><ArticleIdList><ArticleId IdType="pubmed">17937614</ArticleId></ArticleIdList></Reference><Reference><Citation>Maiorino M., Conrad M., Ursini F. GPx4, Lipid Peroxidation, and Cell Death: Discoveries, Rediscoveries, and Open Issues. Antioxid Redox Signal. 2018;29(1):61&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">28462584</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoo M.H., Gu X., Xu X.M., Kim J.Y., Carlson B.A., Patterson A.D., et al. Delineating the role of glutathione peroxidase 4 in protecting cells against lipid hydroperoxide damage and in Alzheimer&#x2019;s disease. Antioxid Redox Signal. 2010;12(7):819&#x2013;827.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2861544</ArticleId><ArticleId IdType="pubmed">19769463</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellinger F.P., Bellinger M.T., Seale L.A., Takemoto A.S., Raman A.V., Miki T., et al. Glutathione Peroxidase 4 is associated with Neuromelanin in Substantia Nigra and Dystrophic Axons in Putamen of Parkinson&#x2019;s brain. Mol Neurodegener. 2011;6(1):8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3037910</ArticleId><ArticleId IdType="pubmed">21255396</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q., Han X., Lan X.i., Gao Y., Wan J., Durham F., et al. Inhibition of neuronal ferroptosis protects hemorrhagic brain. JCI insight. 2017;2(7):e90777.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5374066</ArticleId><ArticleId IdType="pubmed">28405617</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L., Hambright W.S., Na R., Ran Q. Ablation of the Ferroptosis Inhibitor Glutathione Peroxidase 4 in Neurons Results in Rapid Motor Neuron Degeneration and Paralysis. J Biol Chem. 2015;290(47):28097&#x2013;28106.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4653669</ArticleId><ArticleId IdType="pubmed">26400084</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuster D.J., Dykstra J.A., Riedl M.S., Kitto K.F., Belur L.R., McIvor R.S., et al. Biodistribution of adeno-associated virus serotype 9 (AAV9) vector after intrathecal and intravenous delivery in mouse. Front Neuroanat. 2014;8:42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4051274</ArticleId><ArticleId IdType="pubmed">24959122</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu H., Lin H., Duan W., Cui C., Li Z., Liu Y., et al. Intrathecal Injection of scAAV9-hIGF1 Prolongs the Survival of ALS Model Mice by Inhibiting the NF-kB Pathway. Neuroscience. 2018;381:1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">29447858</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L., Haraguchi S., Koda T., Hashimoto K., Nakagawara A. Muscle atrophy and motor neuron degeneration in human NEDL1 transgenic mice. J Biomed Biotechnol. 2011;2011:1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2952905</ArticleId><ArticleId IdType="pubmed">20976258</ArticleId></ArticleIdList></Reference><Reference><Citation>Deacon R.M.J. Measuring the strength of mice. J Vis Exp. 2013 Jun;76</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3725666</ArticleId><ArticleId IdType="pubmed">23770643</ArticleId></ArticleIdList></Reference><Reference><Citation>Aartsma-Rus A., van Putten M. Assessing functional performance in the mdx mouse model. J Vis Exp. 2014;85</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4158772</ArticleId><ArticleId IdType="pubmed">24747372</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatzipetros T., Kidd J.D., Moreno A.J., Thompson K., Gill A., Vieira F.G. A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS. J Vis Exp. 2015 Oct;104</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4692639</ArticleId><ArticleId IdType="pubmed">26485052</ArticleId></ArticleIdList></Reference><Reference><Citation>Folch J., Lees M., Stanley G.H.S. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957;226(1):497&#x2013;509.</Citation><ArticleIdList><ArticleId IdType="pubmed">13428781</ArticleId></ArticleIdList></Reference><Reference><Citation>Maniatis S., &#xc4;ij&#xf6; T., Vickovic S., Braine C., Kang K., Mollbrink A., et al. Spatiotemporal dynamics of molecular pathology in amyotrophic lateral sclerosis. Science. 2019;364(6435):89&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">30948552</ArticleId></ArticleIdList></Reference><Reference><Citation>Golabchi F.N., Sapienza S., Severini G., Reaston P., Tomecek F., Demarchi D., et al. Assessing aberrant muscle activity patterns via the analysis of surface EMG data collected during a functional evaluation. BMC Musculoskelet Disord. 2019;20(1):13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6320612</ArticleId><ArticleId IdType="pubmed">30611235</ArticleId></ArticleIdList></Reference><Reference><Citation>Gatto R.G., Li W., Magin R.L. Diffusion tensor imaging identifies presymptomatic axonal degeneration in the spinal cord of ALS mice. Brain Res. 2018;1679:45&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">29175489</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw B., Valentine J. How do ALS-associated mutations in superoxide dismutase 1 promote aggregation of the protein? Trends Biochem Sci. 2007;32(2):78&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">17208444</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney M.E. The use of transgenic mouse models of amyotrophic lateral sclerosis in preclinical drug studies. J Neurol Sci. 1997 Oct;152(Suppl 1):S67&#x2013;S73.</Citation><ArticleIdList><ArticleId IdType="pubmed">9419057</ArticleId></ArticleIdList></Reference><Reference><Citation>Stockwell B.R., Friedmann Angeli J.P., Bayir H., Bush A.I., Conrad M., Dixon S.J., et al. Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease. Cell. 2017;171(2):273&#x2013;285.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5685180</ArticleId><ArticleId IdType="pubmed">28985560</ArticleId></ArticleIdList></Reference><Reference><Citation>Brigelius-Floh&#xe9; R., Maiorino M. Glutathione peroxidases. Biochim Biophys Acta. 2013;1830(5):3289&#x2013;3303.</Citation><ArticleIdList><ArticleId IdType="pubmed">23201771</ArticleId></ArticleIdList></Reference><Reference><Citation>Ribas V., Garc&#xed;a-Ruiz C., Fern&#xe1;ndez-Checa J.C. Glutathione and mitochondria. Front Pharmacol. 2014;5:151.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4079069</ArticleId><ArticleId IdType="pubmed">25024695</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirrlinger J., Dringen R. The cytosolic redox state of astrocytes: Maintenance, regulation and functional implications for metabolite trafficking. Brain Res Rev. 2010;63(1-2):177&#x2013;188.</Citation><ArticleIdList><ArticleId IdType="pubmed">19883686</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xed;az-Amarilla P., Olivera-Bravo S., Trias E., Cragnolini A., Mart&#xed;nez-Palma L., Cassina P., et al. Phenotypically aberrant astrocytes that promote motoneuron damage in a model of inherited amyotrophic lateral sclerosis. Proc Natl Acad Sci USA. 2011;108(44):18126&#x2013;18131.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3207668</ArticleId><ArticleId IdType="pubmed">22010221</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner M.R., Hardiman O., Benatar M., Brooks B.R., Chio A., de Carvalho M., et al. Controversies and priorities in amyotrophic lateral sclerosis. Lancet Neurol. 2013;12(3):310&#x2013;322.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4565161</ArticleId><ArticleId IdType="pubmed">23415570</ArticleId></ArticleIdList></Reference><Reference><Citation>Oskarsson B., Gendron T.F., Staff N.P. Amyotrophic Lateral Sclerosis: An Update for 2018. Mayo Clin Proc. 2018;93(11):1617&#x2013;1628.</Citation><ArticleIdList><ArticleId IdType="pubmed">30401437</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel D., Witt S.N. Ethanolamine and Phosphatidylethanolamine: Partners in Health and Disease. Oxid Med Cell Longev. 2017;2017:1&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5529665</ArticleId><ArticleId IdType="pubmed">28785375</ArticleId></ArticleIdList></Reference><Reference><Citation>Calzada E., Onguka O., Claypool S.M. Phosphatidylethanolamine Metabolism in Health and Disease. Int Rev Cell Mol Biol. 2016;321:29&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4778737</ArticleId><ArticleId IdType="pubmed">26811286</ArticleId></ArticleIdList></Reference><Reference><Citation>Gautam M., Jara J.H., Kocak N., Rylaarsdam L.E., Kim K.D., Bigio E.H., et al. Mitochondria, ER, and nuclear membrane defects reveal early mechanisms for upper motor neuron vulnerability with respect to TDP-43 pathology. Acta Neuropathol. 2019;137(1):47&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6339587</ArticleId><ArticleId IdType="pubmed">30450515</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang W.S., Stockwell B.R. Ferroptosis: Death by Lipid Peroxidation. Trends Cell Biol. 2016;26(3):165&#x2013;176.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4764384</ArticleId><ArticleId IdType="pubmed">26653790</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang W.S., Kim K.J., Gaschler M.M., Patel M., Shchepinov M.S., Stockwell B.R. Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis. Proc Natl Acad Sci USA. 2016;113(34):E4966&#x2013;E4975.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5003261</ArticleId><ArticleId IdType="pubmed">27506793</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer K., Ferraiuolo L., Miranda C.J., Likhite S., McElroy S., Renusch S., et al. Direct conversion of patient fibroblasts demonstrates non-cell autonomous toxicity of astrocytes to motor neurons in familial and sporadic ALS. Proc Natl Acad Sci USA. 2014;111(2):829&#x2013;832.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3896192</ArticleId><ArticleId IdType="pubmed">24379375</ArticleId></ArticleIdList></Reference><Reference><Citation>Puentes F., Malaspina A., van Noort J.M., Amor S. Non-neuronal Cells in ALS: Role of Glial, Immune cells and Blood-CNS Barriers. Brain Pathol. 2016;26(2):248&#x2013;257.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8029111</ArticleId><ArticleId IdType="pubmed">26780491</ArticleId></ArticleIdList></Reference><Reference><Citation>Liddelow S.A., Guttenplan K.A., Clarke L.E., Bennett F.C., Bohlen C.J., Schirmer L., et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541(7638):481&#x2013;487.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5404890</ArticleId><ArticleId IdType="pubmed">28099414</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo X., Gong H.-B., Gao H.-Y., Wu Y.-P., Sun W.-Y., Li Z.-Q., et al. Oxygenated phosphatidylethanolamine navigates phagocytosis of ferroptotic cells by interacting with TLR2. Cell Death Differ. 2021;28(6):1971&#x2013;1989.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8185102</ArticleId><ArticleId IdType="pubmed">33432112</ArticleId></ArticleIdList></Reference><Reference><Citation>Ioannou M.S., Jackson J., Sheu S.-H., Chang C.-L., Weigel A.V., Liu H., et al. Neuron-Astrocyte Metabolic Coupling Protects against Activity-Induced Fatty Acid Toxicity. Cell. 2019;177(6):1522&#x2013;1535.e14.</Citation><ArticleIdList><ArticleId IdType="pubmed">31130380</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma W., Zhan Y., Zhang Y., Xie X., Mao C., Lin Y. Enhanced Neural Regeneration with a Concomitant Treatment of Framework Nucleic Acid and Stem Cells in Spinal Cord Injury. ACS Appl Mater Interfaces. 2020;12(2):2095&#x2013;2106.</Citation><ArticleIdList><ArticleId IdType="pubmed">31845577</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang T., Tian T., Lin Y. Functionalizing Framework Nucleic Acid-Based Nanostructures for Biomedical Application. Adv Mater. 2021 Nov;17</Citation><ArticleIdList><ArticleId IdType="pubmed">34787933</ArticleId></ArticleIdList></Reference><Reference><Citation>Sneddon A.A., Wu H.-C., Farquharson A., Grant I., Arthur J.R., Rotondo D., et al. Regulation of selenoprotein GPx4 expression and activity in human endothelial cells by fatty acids, cytokines and antioxidants. Atherosclerosis. 2003;171(1):57&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">14642406</ArticleId></ArticleIdList></Reference><Reference><Citation>Ursini F., Maiorino M. Lipid peroxidation and ferroptosis: The role of GSH and GPx4. Free Radic Biol Med. 2020;152:175&#x2013;185.</Citation><ArticleIdList><ArticleId IdType="pubmed">32165281</ArticleId></ArticleIdList></Reference><Reference><Citation>Alim I., Caulfield J.T., Chen Y., Swarup V., Geschwind D.H., Ivanova E., et al. Selenium Drives a Transcriptional Adaptive Program to Block Ferroptosis and Treat Stroke. Cell. 2019;177(5):1262&#x2013;1279.e25.</Citation><ArticleIdList><ArticleId IdType="pubmed">31056284</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang D., Chen X., Kang R., Kroemer G. Ferroptosis: molecular mechanisms and health implications. Cell Res. 2021;31(2):107&#x2013;125.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8026611</ArticleId><ArticleId IdType="pubmed">33268902</ArticleId></ArticleIdList></Reference><Reference><Citation>Ufer C., Wang C.C., F&#xe4;hling M., Schiebel H., Thiele B.J., Billett E.E., et al. Translational regulation of glutathione peroxidase 4 expression through guanine-rich sequence-binding factor 1 is essential for embryonic brain development. Genes Dev. 2008;22(13):1838&#x2013;1850.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2492670</ArticleId><ArticleId IdType="pubmed">18593884</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z., Geng Y., Lu X., Shi Y., Wu G., Zhang M., et al. Chaperone-mediated autophagy is involved in the execution of ferroptosis. Proc Natl Acad Sci USA. 2019;116(8):2996&#x2013;3005.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6386716</ArticleId><ArticleId IdType="pubmed">30718432</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>